Paxmedica announces pricing of $7.0 million public offering

Tarrytown, ny / accesswire / november 20, 2023 / paxmedica, inc. (nasdaq:pxmd) ("paxmedica" or the "company"), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the pricing of its public offering of an aggregate of 5,384,615 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,384,615 shares of common stock, at a combined public offering price of $1.30 per share (or common stock equivalent in lieu thereof) and accompanying warrant. the warrants will have an exercise price of $1.30 per share, will be exercisable immediately upon issuance, and will expire five years after the initial exercise date.
PXMD Ratings Summary
PXMD Quant Ranking